After observing that NOXA expression sensitized SS cell lines to venetoclax and S63845 similarly sensitized SS cell lines, we chose to expand our investigation into the efficacy of venetoclax in combination with S63845 as a therapy for SS. Here, PMAIP1 is linked to synovial sarcoma.